NCT05526794

Brief Summary

The aim of this research is to examine the effects of the anesthesia method and preoperative characteristics on postoperative results and complications in patients who underwent percutaneous kyphoplasty (PKP). Method: Patients were split into three groups according to anesthesia methods: (1) General Anesthesia (Sedation), (2) Central Block (Spinal and Epidural Anesthesia), (3) Peripheral Block \[Erector Spina Plane Block (ESPB), and Paravertebral Block (PVB)\]. Patients' pain values, hemodynamic parameters, additional need for sedation, and perioperative and postoperative complications were recorded prospectively together with Visual Pain Scales (VAS).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2022

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

August 25, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 2, 2022

Completed
Last Updated

September 2, 2022

Status Verified

August 1, 2022

Enrollment Period

6 months

First QC Date

August 25, 2022

Last Update Submit

August 31, 2022

Conditions

Keywords

percutan kyphoplastyVertebroplasty

Outcome Measures

Primary Outcomes (1)

  • Postoperative Visual Analog Scala (VAS) values

    VAS is a scala between 0-10 points. If there is no pain it means 0; very severe pain is 10 points.

    VAS values at postoperative 24 hours

Secondary Outcomes (1)

  • Analgesic consumption

    postoperative 24 hours after surgery

Study Arms (3)

Group 1

General anesthesia or sedation

Procedure: Analgesic consumption

Group 2

Central Block (Spinal and Epidural Anesthesia

Procedure: Analgesic consumption

Group 3

Peripheral Block \[Erector Spina Plane Block (ESPB), and Paravertebral Block (PVB)

Procedure: Analgesic consumption

Interventions

1 gr iv paracetamol for all patients with a VAS value of 2 or 3; for 4 and over, 1.5 mg/kg iv tramadol was administered additionally.

Group 1Group 2Group 3

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

18-100 aged kyphoplasty patients

You may qualify if:

  • ages kyphoplasty surgery patients
  • written consent form received

You may not qualify if:

  • The patient's unwillingness to participate in the study
  • inability to communicate with the patient
  • the patient does not speak Turkish,
  • previous CVO, presence of cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bursa Training and Research Hospital

Bursa, 16600, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Spinal Fractures

Condition Hierarchy (Ancestors)

Spinal InjuriesBack InjuriesWounds and InjuriesFractures, Bone

Study Officials

  • Tuğba T Onur, MD

    Bursa Yuksek Ihtisas Training and Research Hospital

    PRINCIPAL INVESTIGATOR
  • Ümran Ü Karaca, MD

    Bursa Yuksek Ihtisas Training and Research Hospital

    STUDY CHAIR
  • Asiye A Demirel, MD

    Bursa Yuksek Ihtisas Training and Research Hospital

    STUDY CHAIR
  • Şeyda Efsun ŞE Özgünay, Assoc Prof

    Bursa Yuksek Ihtisas Training and Research Hospital

    STUDY CHAIR
  • Anıl A Onur, MD

    Bursa Medicabil Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal İnvestigator

Study Record Dates

First Submitted

August 25, 2022

First Posted

September 2, 2022

Study Start

January 1, 2022

Primary Completion

July 1, 2022

Study Completion

August 1, 2022

Last Updated

September 2, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

With the written consent of the patients and the approval of the ethics committee, I do not intend to share their special circumstances and information other than the study data.

Locations